BREYANZI is a Kit in the Cellular Therapy category. It is labeled and distributed by Juno Therapeutics, Inc.. The primary component is .
Product ID | 73153-900_0dc7e1de-7a6d-4931-bcc1-f82c5edf6d2b |
NDC | 73153-900 |
Product Type | Cellular Therapy |
Proprietary Name | BREYANZI |
Generic Name | Lisocabtagene Maraleucel |
Dosage Form | Kit |
Marketing Start Date | 2021-02-05 |
Marketing Category | BLA / BLA |
Application Number | BLA125714 |
Labeler Name | Juno Therapeutics, Inc. |
Active Ingredient Strength | 0 |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2021-02-05 |
NDC Exclude Flag | N |
Sample Package? | N |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
BREYANZI 90300948 not registered Live/Pending |
JUNO THERAPEUTICS, INC. 2020-11-05 |
BREYANZI 90300931 not registered Live/Pending |
JUNO THERAPEUTICS, INC. 2020-11-05 |
BREYANZI 88569196 not registered Live/Pending |
JUNO THERAPEUTICS, INC. 2019-08-07 |
BREYANZI 88077381 not registered Live/Pending |
Celgene Corporation 2018-08-14 |